otherMar 5, 2016Closed access

Polycystic ovary syndrome

JLJudy LawrencePDPauline DouglasJGJoan Gandy

King's College London · The University of Adelaide · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic…

Citation impact

1,015
total citations
FWCI
Percentile
References
94
Citations per year

Authors

3
  • JL
    Judy LawrenceCorresponding

    King's College London, The University of Adelaide

  • PD
    Pauline Douglas

    University of Ulster, Food for Health Ireland, Hôpital Jeanne de Flandre

  • JG
    Joan Gandy

    University of Hertfordshire, Penn State Milton S. Hershey Medical Center

Topics & keywords

Keywords
  • Polycystic ovary
  • Gestational diabetes
  • Insulin resistance
  • Medicine
  • Type 2 diabetes
  • Intervention (counseling)
  • Gynecology
  • Diabetes mellitus
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.